Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-year prospective cohort study

被引:138
|
作者
Park, Sung Keun [1 ]
Seo, Mi Hae [2 ]
Shin, Ho Cheol [3 ]
Ryoo, Jae-Hong [4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Total Healthcare Ctr, Kangbuk Samsung Hosp, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Kangbuk Samsung Hosp, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Family Med, Kangbuk Samsung Hosp, Seoul, South Korea
[4] Kyung Hee Univ, Dept Prevent Med, Sch Med, Seoul 130701, South Korea
关键词
BETA-CELL FUNCTION; INSULIN-RESISTANCE; PREVALENCE; GLUCOSE;
D O I
10.1002/hep.26183
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There have been several reports about the clinical association between type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). However, most of the studies were about the unilateral effects of type 2 DM on NAFLD, and studies on the reverse relation are rare. Thus, this study was designed to investigate the effect of NAFLD on type 2 DM. We conducted a prospective cohort study on 25,232 Korean men without type 2 DM for 5 years. We serially checked the various metabolic factors including fasting glucose and hemoglobin A1c (HbA1c), and monitored the development of type 2 DM. The incidence rate of type 2 DM was compared according to the degree of NAFLD (normal, mild, and moderate to severe), and a Cox proportional hazards model was used to measure the hazard ratios (HRs) of NAFLD on type 2 DM. The incidence rate of type 2 DM increased according to the degree of NAFLD (normal: 7.0%, mild: 9.8%, moderate to severe: 17.8%, P < 0.001). Even after adjusting for other multiple covariates, the HRs (95% confidence interval [CI]) for type 2 DM development was higher in the mild group (1.09; 0.81-1.48) and moderate to severe group (1.73; 1.00-3.01) compared to the normal group, respectively (P for trend <0.001). Conclusion: The development of type 2 DM is potentially more associated with more progressive NAFLD than a normal or milder state. In addition, NAFLD was an independent risk factor for the future development of type 2 DM. These results suggest the potential availability of NAFLD as an early predictor of type 2 DM. (HEPATOLOGY 2013;57:13781383)
引用
收藏
页码:1378 / 1383
页数:6
相关论文
共 50 条
  • [11] Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
    Bril, Fernando
    Cusi, Kenneth
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (04) : 765 - +
  • [12] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
    Ismail, Mona H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (06): : 485 - 492
  • [13] Liver Enzymes, Fatty Liver and Type 2 Diabetes Mellitus in a Jinchang Cohort: A Prospective Study in Adults
    Zhang, Jianping
    Cheng, Ning
    Ma, Yubao
    Li, Haiyan
    Cheng, Zhiyuan
    Yang, Yanxu
    He, Caili
    Li, Juansheng
    Pu, Hongquan
    Shen, Xiping
    Ren, Xiaoyu
    Shi, Dian
    Pu, Ruiyang
    Gan, Ting
    Ding, Jiao
    Zheng, Tongzhang
    Bai, Yana
    CANADIAN JOURNAL OF DIABETES, 2018, 42 (06) : 652 - 658
  • [14] Efficacy and Safety of Sitagliptin for the Treatment of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes Mellitus
    Fukuhara, Takayuki
    Hyogo, Hideyuki
    Ochi, Hidenori
    Fujino, Hatsue
    Kan, Hiromi
    Naeshiro, Noriaki
    Honda, Yohji
    Miyaki, Daisuke
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Chayama, Kazuaki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (130) : 323 - 328
  • [15] Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Moh, Myint Aung Moh
    Jung, Chan-Hee
    Lee, Bora
    Choi, Dughyun
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Mok, Ji-Oh
    DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (02): : 186 - 195
  • [16] The Role of Muscle Decline in Type 2 Diabetes Development: A 5-Year Prospective Observational Cohort Study
    Maliszewska, Katarzyna
    Adamska-Patruno, Edyta
    Goscik, Joanna
    Lipinska, Danuta
    Citko, Anna
    Krahel, Aleksandra
    Miniewska, Katarzyna
    Fiedorczuk, Joanna
    Moroz, Monika
    Gorska, Maria
    Kretowski, Adam
    NUTRIENTS, 2019, 11 (04)
  • [17] The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Dai, Chia-Yen
    Fang, Tzu-Jung
    Hung, Wei-Wen
    Tsai, Hui-Ju
    Tsai, Yi-Chun
    BIOMEDICINES, 2022, 10 (07)
  • [18] Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus
    Paola Portillo-Sanchez
    Kenneth Cusi
    Clinical Diabetes and Endocrinology, 2 (1):
  • [19] Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
    Cho, Hyo Jung
    Hwang, Sunhyuk
    Park, Jong Ik
    Yang, Min Jae
    Hwang, Jae Chul
    Yoo, Byung Moo
    Lee, Kee Myung
    Shin, Sung Jae
    Lee, Kwang Jae
    Kim, Jin Hong
    Cheong, Jae Youn
    Cho, Sung Won
    Kim, Soon Sun
    GUT AND LIVER, 2019, 13 (04) : 440 - 449
  • [20] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Nar, A.
    Gedik, O.
    ACTA DIABETOLOGICA, 2009, 46 (02) : 113 - 118